Pillstats
Rx only · Tablet · Oral

Mycophenolate Mofetil

Mycophenolate Mofetil

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)68149
US makers5 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.080$0.161$0.241$0.322Dec 2025Apr 2026Jul 2026
$0.273
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
4
Active US suppliers
63%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.2K4.4K6.6K8.8K2025 Q12025 Q22025 Q32025 Q42026 Q1
6.4K
Rx · 2026 Q1
903K
Units dispensed
-10%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Concord Biotech Limitedunknown3SUPPLYING
Advagen Pharma Ltdunknown2SUPPLYING
Accord Healthcare Inc.unknown2SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown2EXITED 2026

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.